Interleukin 18 and interleukin 22 as important immune markers in patients with tuberculosis
Tuberculosis (TB) is a lung infection caused by the bacterium Mycobacterium tuberculosis (MTB). TB is a leading cause of death globally, accounting for approximately 1.5 million deaths per year. The aim of this article was to evaluate the immunological role of Interleukin (IL) 18 and Interleukin 22...
Main Authors: | Kamoona Firas Mohammad Hussein, Aljanaby Ahmed Abduljabbar Jaloob |
---|---|
Format: | Article |
Language: | English |
Published: |
EDP Sciences
2023-01-01
|
Series: | E3S Web of Conferences |
Subjects: | |
Online Access: | https://www.e3s-conferences.org/articles/e3sconf/pdf/2023/26/e3sconf_uesf2023_03109.pdf |
Similar Items
-
CD4 and CD20 as important immune markers in patients with pulmonary tuberculosis
by: Kamoona Firas Mohammad Hussein, et al.
Published: (2023-01-01) -
Interleukin-18, Functional IL-18 Receptor and IL-18 Binding Protein Expression in Active and Latent Tuberculosis
by: Sebastian Wawrocki, et al.
Published: (2020-06-01) -
Utility of GeneXpert MTB/RIF assay for the diagnosis of pulmonary and extra-pulmonary tuberculosis, A report from Egypt
by: Enas, M. Hefzy, et al.
Published: (2021-02-01) -
Pulmoner ve ekstrapulmoner örneklerde tüberkülozun erken tanısı ve rifampisin direncinin tespiti için geneXpert MTB/RIF testinin değerlendirilmesi
by: Ali Albay, et al.
Published: (2016-09-01) -
Interleukin-22 and interleukin-33 show up-regulated levels in the serum of patients with mild/moderate Coronavirus disease 2019
by: Abdulraheem Y. Majeed, et al.
Published: (2023-02-01)